Stock 0QMX SHL TELEMEDICINE LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Other languages SHL Telemedicine Ltd. CBOE EUROPE EQUITIES

Equities

0QMX

IL0010855885

End-of-day quote CBOE EUROPE EQUITIES
Other stock markets
- CHF - Intraday chart for SHL Telemedicine Ltd.
05-21 Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Fresh Catalysts MT
05-21 SHL Telemedicine Launches At-Home Blood Test for Heart Attack Detection in Israel MT

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
SHL Telemedicine expands offering in Israel with groundbreakingat-home Biomarker blood test
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Tuesday as Investors Await Fresh Catalysts
SHL Telemedicine Launches At-Home Blood Test for Heart Attack Detection in Israel
SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test
SHL Telemedicine Ltd. Expands Offering in Israel with Groundbreaking At-Home Biomarker Blood Test
SHL Telemedicine Announces Official Launch of SmartHeart D2C Membership in the US Following Successful Soft Launch
SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch
SHL Telemedicine : announces Special General Meeting Results - Form 6-K
SHL Telemedicine : announces Special General Meeting Results
SHL Telemedicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
SHL Announces Full-Year 2023 Results, Stable Revenue Growth alongside Groundbreaking Clinical Milestones
Transcript : SHL Telemedicine Ltd., 2023 Earnings Call, Apr 17, 2024
SHL Telemedicine Logs Revenue Growth in FY23
SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones
SHL Telemedicine Reports Wider FY23 Attributable Loss
Imperial College London study shows groundbreaking final results for SHL Telemedicine's SmartHeart in Post-ACS patient care
Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care
SHL Telemedicine Ltd. Announces Full Results of the Imperial College London Tele-ACS Trial
SHL Telemedicine's SmartHeart Technology Triumphs in US Army Project Convergence, Capstone 4 Experiment
SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SHLTN Stock
  4. 0QMX Stock
  5. News SHL Telemedicine Ltd.
  6. Other languages